HLNCF:OTCMKTS
Haleon PLC
$4.89
arrow_upward
+0.85%(+0.041) 1D
Oct 15, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
$4.95
High
$4.95
Low
$4.89
Mkt. cap
43.44B
Avg. vol.
9.92K
Volume
4.56K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.47
Shares outstanding
8.80B
No. of employees
25K
Open
$4.95
High
$4.95
Low
$4.89
Mkt. cap
43.44B
Avg. vol.
9.92K
Volume
4.56K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.47
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
11 hours ago
UBS trims Haleon growth forecast to 3.1 percent for Haleon stock
Yahoo Finance
·
21 hours ago
Is Haleon (LSE:HLN) Using Excedrin’s Nostalgic Game To Redefine Consumer Health Brand Moats?
Simply Wall Street
·
1 day ago
Haleon (LSE:HLN) Stock May Be 43% Undervalued On Cash Flow
Yahoo Finance
·
1 day ago
Is Haleon (LSE:HLN) Undervalued After A 11% Three Year Return?
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC